|
1
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar
|
|
2
|
Figueredo A, Coombes ME and Mukherjee S:
Adjuvant therapy for completely resected stage II colon cancer.
Cochrane Database Syst Rev. CD0053902008.PubMed/NCBI
|
|
3
|
Cunningham D, Atkin W, Lenz HJ, Lynch HT,
Minsky B, Nordlinger B and Starling N: Colorectal cancer. Lancet.
375:1030–1047. 2010. View Article : Google Scholar
|
|
4
|
Yu W, Gius D, Onyango P, Muldoon-Jacobs K,
Karp J, Feinberg AP and Cui H: Epigenetic silencing of tumour
suppressor gene p15 by its antisense RNA. Nature. 451:202–206.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou
W and Dong JT: Implication of snoRNA U50 in human breast cancer. J
Genet Genomics. 36:447–454. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Calin GA and Croce CM: MicroRNA signatures
in human cancers. Nat Rev Cancer. 6:857–866. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Esquela-Kerscher A and Slack FJ: Oncomirs
– microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269.
2006.
|
|
9
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
Downing JR, Jacks T, Horvitz HR and Golub TR: MicroRNA expression
profiles classify human cancers. Nature. 435:834–838. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Duan R, Pak C and Jin P: Single nucleotide
polymorphism associated with mature miR-125a alters the processing
of pri-miRNA. Hum Mol Genet. 16:1124–1131. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lujambio A, Ropero S, Ballestar E, Fraga
MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A,
Sanchez-Cespedes M, Git A, Spiteri I, Das PP, Caldas C, Miska E and
Esteller M: Genetic unmasking of an epigenetically silenced
microRNA in human cancer cells. Cancer Res. 67:1424–1429. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saunders MA, Liang H and Li WH: Human
polymorphism at microRNAs and microRNA target sites. Proc Natl Acad
Sci USA. 104:3300–3305. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iwai N and Naraba H: Polymorphisms in
human pre-miRNAs. Biochem Biophys Res Commun. 331:1439–1444. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen H, Sun LY, Chen LL, Zheng HQ and
Zhang QF: A variant in microRNA-196a2 is not associated with
susceptibility to and progression of colorectal cancer in Chinese.
Intern Med J. Jan. 17–2011.(E-pub ahead of print).
|
|
15
|
Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L,
Zeng Y, Miao R, Jin G, Ma H, Chen Y and Shen H: Genetic variants of
miRNA sequences and non-small cell lung cancer survival. J Clin
Invest. 118:2600–2608. 2008.PubMed/NCBI
|
|
16
|
Lee HC, Kim JG, Chae YS, Sohn SK, Kang BW,
Moon JH, Jeon SW, Lee MH, Lim KH, Park JY, Choi GS and Jun SH:
Prognostic impact of microRNA-related gene polymorphisms on
survival of patients with colorectal cancer. J Cancer Res Clin
Oncol. 136:1073–1078. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Griffiths-Jones S: The microRNA registry.
Nucleic Acids Res. 32:D109–D111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Landi D, Gemignani F, Naccarati A, Pardini
B, Vodicka P, Vodickova L, Novotny J, Forsti A, Hemminki K, Canzian
F and Landi S: Polymorphisms within micro-RNA-binding sites and
risk of sporadic colorectal cancer. Carcinogenesis. 29:579–584.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Landi D, Moreno V, Guino E, Vodicka P,
Pardini B, Naccarati A, Canzian F, Barale R, Gemignani F and Landi
S: Polymorphisms affecting micro-RNA regulation and associated with
the risk of dietary-related cancers: a review from the literature
and new evidence for a functional role of rs17281995 (CD86) and
rs1051690 (INSR), previously associated with colorectal cancer.
Mutat Res. Oct. 30–2010.(E-pub ahead of print).
|
|
20
|
Boni V, Zarate R, Villa JC, Bandres E,
Gomez MA, Maiello E, Garcia-Foncillas J and Aranda E: Role of
primary miRNA polymorphic variants in metastatic colon cancer
patients treated with 5-fluorouracil and irinotecan.
Pharmacogenomics J. June 29–2010.(E-pub ahead of print).
|
|
21
|
Graziano F, Canestrari E, Loupakis F,
Ruzzo A, Galluccio N, Santini D, Rocchi M, Vincenzi B, Salvatore L,
Cremolini C, Spoto C, Catalano V, D'Emidio S, Giordani P, Tonini G,
Falcone A and Magnani M: Genetic modulation of the Let-7 microRNA
binding to KRAS 3′-untranslated region and survival of metastatic
colorectal cancer patients treated with salvage
cetuximab-irinotecan. Pharmacogenomics J. 10:458–464. 2010.
|
|
22
|
Zhang W, Winder T, Ning Y, Pohl A, Yang D,
Kahn M, Lurje G, Labonte MJ, Wilson PM, Gordon MA, Hu-Lieskovan S,
Mauro DJ, Langer C, Rowinsky EK and Lenz HJ: A let-7
microRNA-binding site polymorphism in 3′-untranslated region of
KRAS gene predicts response in wild-type KRAS patients with
metastatic colorectal cancer treated with cetuximab monotherapy.
Ann Oncol. 22:104–109. 2011.
|
|
23
|
Hoffman AE, Zheng T, Yi C, Leaderer D,
Weidhaas J, Slack F, Zhang Y, Paranjape T and Zhu Y: microRNA
miR-196a-2 and breast cancer: a genetic and epigenetic association
study and functional analysis. Cancer Res. 69:5970–5977. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hu Z, Liang J, Wang Z, Tian T, Zhou X,
Chen J, Miao R, Wang Y, Wang X and Shen H: Common genetic variants
in pre-microRNAs were associated with increased risk of breast
cancer in Chinese women. Hum Mutat. 30:79–84. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tian T, Shu Y, Chen J, Hu Z, Xu L, Jin G,
Liang J, Liu P, Zhou X, Miao R, Ma H, Chen Y and Shen H: A
functional genetic variant in microRNA-196a2 is associated with
increased susceptibility of lung cancer in Chinese. Cancer
Epidemiol Biomarkers Prev. 18:1183–1187. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu J, Hu Z, Xu Z, Gu H, Yi L, Cao H, Chen
J, Tian T, Liang J, Lin Y, Qiu W, Ma H, Shen H and Chen Y:
Functional variant in microRNA-196a2 contributes to the
susceptibility of congenital heart disease in a Chinese population.
Hum Mutat. 30:1231–1236. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qi P, Dou TH, Geng L, Zhou FG, Gu X, Wang
H and Gao CF: Association of a variant in MIR196A2 with
susceptibility to hepatocellular carcinoma in male Chinese patients
with chronic hepatitis B virus infection. Hum Immunol. 71:621–626.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Peng S, Kuang Z, Sheng C, Zhang Y, Xu H
and Cheng Q: Association of microRNA-196a-2 gene polymorphism with
gastric cancer risk in a Chinese population. Dig Dis Sci.
55:2288–2293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Iorio MV, Ferracin M, Liu CG, Veronese A,
Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M,
Menard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I,
Calin GA, Querzoli P, Negrini M and Croce CM: MicroRNA gene
expression deregulation in human breast cancer. Cancer Res.
65:7065–7070. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Porkka KP, Pfeiffer MJ, Waltering KK,
Vessella RL, Tammela TL and Visakorpi T: MicroRNA expression
profiling in prostate cancer. Cancer Res. 67:6130–6135. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Schwind S, Maharry K, Radmacher MD, Mrozek
K, Holland KB, Margeson D, Whitman SP, Hickey C, Becker H, Metzeler
KH, Paschka P, Baldus CD, Liu S, Garzon R, Powell BL, Kolitz JE,
Carroll AJ, Caligiuri MA, Larson RA, Marcucci G and Bloomfield CD:
Prognostic significance of expression of a single microRNA,
miR-181a, in cytogenetically normal acute myeloid leukemia: a
Cancer and Leukemia Group B study. J Clin Oncol. 28:5257–5264.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
Mitsudomi T and Takahashi T: Reduced expression of the let-7
microRNAs in human lung cancers in association with shortened
postoperative survival. Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Schetter AJ, Leung SY, Sohn JJ, Zanetti
KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, Liu
CG, Calin GA, Croce CM and Harris CC: MicroRNA expression profiles
associated with prognosis and therapeutic outcome in colon
adenocarcinoma. JAMA. 299:425–436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xi Y, Formentini A, Chien M, Weir DB,
Russo JJ, Ju J and Kornmann M: Prognostic values of microRNAs in
colorectal cancer. Biomark Insights. 2:113–121. 2006.PubMed/NCBI
|
|
35
|
Schepeler T, Reinert JT, Ostenfeld MS,
Christensen LL, Silahtaroglu AN, Dyrskjot L, Wiuf C, Sorensen FJ,
Kruhoffer M, Laurberg S, Kauppinen S, Orntoft TF and Andersen CL:
Diagnostic and prognostic microRNAs in stage II colon cancer.
Cancer Res. 68:6416–6424. 2008. View Article : Google Scholar : PubMed/NCBI
|
